Veeva Systems Inc. (VEEV) Q1 2027 Financial Results Summary

2026-06-04 · Stocks · QuoteReporter

Veeva Systems Inc. (VEEV) Q1 2027: Revenue Growth Accelerates — Positive Outlook

Veeva Systems Inc. (NYSE: VEEV) reported its fiscal 2027 first-quarter results, showcasing a robust performance with total revenues of $882.9 million, reflecting an increase of $123.9 million or 16% year over year from $759.0 million in the same quarter last year. This growth was primarily driven by a 15% year-over-year increase in subscription revenues, which reached $730.2 million, up from $634.8 million.

This quarter's results are a positive development for shareholders, indicating strong demand for Veeva's cloud solutions in the life sciences sector. The company not only met but exceeded its guidance across all metrics, which is a strong indicator of operational efficiency and market positioning.

Key Financial Metrics:

Total Revenues: $882.9 million, up 16% YoY from $759.0 million.
Subscription Revenues: $730.2 million, up 15% YoY from $634.8 million.
Operating Income: $273.1 million, up 17% YoY from $233.7 million.
Non-GAAP Operating Income: $395.4 million, up 13% YoY from $349.9 million.
Net Income: $260.9 million, up 14% YoY from $228.2 million.
Non-GAAP Net Income: $371.1 million, up 13% YoY from $327.8 million.
Diluted Net Income per Share: $1.57, up from $1.37 YoY.
Non-GAAP Diluted Net Income per Share: $2.24, up from $1.97 YoY.

Shareholder Returns and Guidance

Veeva's management expressed satisfaction with the quarter's performance, highlighting broad-based growth and profitability. The company has raised its fiscal 2027 guidance, projecting total revenues between $3,635 million and $3,645 million and non-GAAP operating income of about $1,610 million. For the fiscal second quarter ending July 31, 2026, Veeva expects total revenues between $902 million and $905 million and non-GAAP fully diluted net income per share between $2.21 and $2.22.

Strategic Developments

Veeva's strategic focus on AI is noteworthy, with significant advancements in its Veeva AI initiatives. The acquisition of Ostro is expected to enhance its capabilities in delivering compliant conversational AI, which is already being utilized for over 50 brands. The upcoming release of Veeva Falcon, aimed at improving productivity in clinical, regulatory, and safety processes, is anticipated to generate strong customer interest.

Forward-Looking Catalysts

Investors should keep an eye on Veeva's continued expansion in AI and its impact on revenue growth. The upcoming release of Veeva Falcon in November and the expansion of Vault AI across all applications in August are critical developments that could further enhance Veeva's market position and drive future revenue growth. Additionally, the company's ability to maintain its growth trajectory amid evolving market dynamics will be crucial for sustaining investor confidence.

In summary, Veeva's first-quarter results for fiscal 2027 reflect a strong performance with significant year-over-year growth in revenues and profitability. The raised guidance and strategic advancements in AI position the company favorably for the upcoming quarters, making it an attractive prospect for investors looking for growth in the life sciences technology sector.

Note: All amounts are in thousands.

Three months ended	April 30, 2026	April 30, 2025
Revenues:	-	-
Subscription(3)	$730,175	$634,768
Professional services and other(4)	152,773	124,275
Total revenues	882,948	759,043
Cost of revenues(5):	-	-
Cost of subscription	99,103	78,346
Cost of professional services and other	121,821	95,478
Total cost of revenues	220,924	173,824
Gross profit	662,024	585,219
Operating expenses(5):	-	-
Research and development	208,323	184,033
Sales and marketing	111,117	98,628
General and administrative	69,472	68,826
Total operating expenses	388,912	351,487
Operating income	273,112	233,732
Other income, net	74,418	65,089
Income before income taxes	347,530	298,821
Income tax provision	86,594	70,631
Net income	$260,936	$228,190
Net income per share:	-	-
Basic	$1.60	$1.40
Diluted	$1.57	$1.37
Weighted-average shares used to compute	-	-
net income per share:	-	-
Basic	163,345	162,749
Diluted	165,989	166,229
Other comprehensive income:	-	-
Net change in unrealized (loss) gain on	$-27,451	$17,367
available-for-sale investments	-	-
Net change in cumulative foreign	-501	-38
currency translation loss	-	-
Comprehensive income	$232,984	$245,519